Literature DB >> 15762683

Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.

Yu-Hsin Lin1, Ching-Kuang Chung, Chiung-Tong Chen, Hsiang-Fa Liang, Sung-Ching Chen, Hsing-Wen Sung.   

Abstract

In this study, a novel nanoparticle system for paracellular transport was prepared using a simple and mild ionic-gelation method upon addition of a poly-gamma-glutamic acid (gamma-PGA) solution into a low-molecular-weight chitosan (low-MW CS) solution. The particle size and the zeta potential value of the prepared nanoparticles can be controlled by their constituted compositions. The results obtained by the TEM and AFM examinations showed that the morphology of the prepared nanoparticles was spherical in shape. Evaluation of the prepared nanoparticles in enhancing intestinal paracellular transport was investigated in vitro in Caco-2 cell monolayers. It was found that the nanoparticles with CS dominated on the surfaces could effectively reduce the transepithelial electrical resistance (TEER) of Caco-2 cell monolayers. After removal of the incubated nanoparticles, a gradual increase in TEER was noticed. The confocal laser scanning microscopy observations confirmed that the nanoparticles with CS dominated on the surface were able to open the tight junctions between Caco-2 cells and allowed transport of the nanoparticles via the paracellular pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762683     DOI: 10.1021/bm049312a

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  17 in total

1.  Biosynthesis of highly pure poly-γ-glutamic acid for biomedical applications.

Authors:  Catarina Leite Pereira; Joana Costa Antunes; Raquel Madeira Gonçalves; Frederico Ferreira-da-Silva; Mário Adolfo Barbosa
Journal:  J Mater Sci Mater Med       Date:  2012-04-25       Impact factor: 3.896

2.  Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

Review 3.  In vitro and in vivo models for the study of oral delivery of nanoparticles.

Authors:  Jennifer M Gamboa; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2013-02-13       Impact factor: 15.470

4.  Poly(γ-glutamic acid) and poly(γ-glutamic acid)-based nanocomplexes enhance type II collagen production in intervertebral disc.

Authors:  Joana C Antunes; Catarina Leite Pereira; Graciosa Q Teixeira; Ricardo V Silva; Joana Caldeira; Sibylle Grad; Raquel M Gonçalves; Mário A Barbosa
Journal:  J Mater Sci Mater Med       Date:  2016-11-24       Impact factor: 3.896

Review 5.  Mucosal vaccine delivery: Current state and a pediatric perspective.

Authors:  Akhilesh Kumar Shakya; Mohammed Y E Chowdhury; Wenqian Tao; Harvinder Singh Gill
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

6.  Macrophage response to chitosan/poly-(γ-glutamic acid) nanoparticles carrying an anti-inflammatory drug.

Authors:  Raquel Madeira Gonçalves; Ana Catarina Leite Pereira; Inês Odila Pereira; Maria José Oliveira; Mário Adolfo Barbosa
Journal:  J Mater Sci Mater Med       Date:  2015-03-20       Impact factor: 3.896

7.  Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions.

Authors:  Gen Zhang; Lei Ding; Randall Renegar; Xuemei Wang; Qun Lu; Shouquan Huo; Yan-Hua Chen
Journal:  Cancer Sci       Date:  2011-05-10       Impact factor: 6.716

8.  Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles.

Authors:  Bin Wang; Ling Tan; Dengpu Deng; Ting Lu; Changwei Zhou; Zhongkui Li; Zhenjie Tang; Zhongshi Wu; Hao Tang
Journal:  Int J Nanomedicine       Date:  2015-05-08

9.  Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.

Authors:  Maria Abdul Ghafoor Raja; Haliza Katas; Thum Jing Wen
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

10.  A Novel Formulation of Cisplatin with γ-Polyglutamic Acid and Chitosan Reduces Its Adverse Renal Effects: An In Vitro and In Vivo Animal Study.

Authors:  Masao Sasai; Kazuma Sakura; Takayuki Matsuda; Hiroshi Uyama
Journal:  Polymers (Basel)       Date:  2021-05-30       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.